GA (weeks) | Birthweight (gm) | Sex | Associated conditions | Treprostinil (PND) | Conditions at treprostinil start | Outcomes | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Weight (g) | Mode of ventilator | RSS | Inhaled NO (ppm) | At 4 weeks | At discharge | ||||||
Non-responder | 34.7 | 2,540 | Male | CDH | 1 | 2,540 | HFOV | 9.8 | 70 | Died | |
34 | 2,050 | Male | CDH | 7 | 2,430 | HFOV | 8 | 80 | Died | ||
31.1 | 1,210 | Male | Down syndrome | 73 | 2,620 | HFOV | 11 | 80 | Died | ||
23.6 | 660 | Male | PPHN | 11 | 920 | HFOV | 12.4 | 40 | Died | ||
27.4 | 1,140 | Male | PPHN | 4 | 1,440 | HFOV | 8.4 | 50 | Survived | Survived | |
34.7 | 2,600 | Female | PPHN | 14 | 2,650 | HFOV | 13.6 | 80 | Died | ||
33.1 | 2,010 | Male | PPHN, Potter sequence | 1 | 2,010 | HFOV | 11.2 | 60 | Died | ||
28.4 | 390 | Female | Severe BPD | 314 | 7,350 | HFOV | 8.4 | 20 | Survived | Survived | |
26.9 | 830 | Female | Severe BPD | 298 | 4,920 | Conventional | 13.6 | 11 | Survived | Survived | |
24.9 | 770 | Female | Severe BPD | 39 | 1,460 | HFOV | 16 | 40 | Survived | Survived | |
24.4 | 710 | Male | Severe BPD | 18 | 700 | Conventional | 12.4 | 80 | Died | ||
Responder | 35.7 | 2,340 | Male | CDH | 10 | 2,900 | HFOV | 8.4 | 40 | Survived | Died |
30.6 | 600 | Male | PPHN, Severe BPD | 4 | 530 | HFOV | 6.2 | 40 | Survived | Survived | |
24.9 | 700 | Male | Severe BPD | 19 | 850 | Conventional | 6 | 30 | Survived | Died | |
24.4 | 690 | Female | Severe BPD | 32 | 890 | HFOV | 6.6 | 60 | Survived | Survived | |
33.4 | 2,490 | Female | Severe BPD | 121 | 5,110 | Conventional | 12.9 | 60 | Survived | Survived | |
30.9 | 740 | Male | Severe BPD, | 45 | 1,340 | Conventional | 18 | 40 | Survived | Died | |
31.9 | 790 | Male | EA, severe BPD, chylothorax | 54 | 1,750 | Conventional | 16.1 | 80 | Survived | Died |